Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review

Author:

Brands Henrike Jacoba1,Van Dijk Brigit1,Brohet Richard M.2,van Westreenen Henderik L.3ORCID,de Groot Jan Willem B.4,Moons Leon M. G.5,de Vos tot Nederveen Cappel Wouter H.1

Affiliation:

1. Gastroenterology and Hepatology, Isala Hospital, 8025 AB Zwolle, The Netherlands

2. Department of Epidemiology and Statistics, Isala Hospital, 8025 AB Zwolle, The Netherlands

3. Abdominal Surgery, Isala Hospital, 8025 AB Zwolle, The Netherlands

4. Isala Oncology Center, Isala Hospital, 8025 AB Zwolle, The Netherlands

5. Gastroenterology and Hepatology, Universitair Medisch Centrum Utrecht, 3584 CX Utrecht, The Netherlands

Abstract

If Colorectal cancer (CRC) is detected and treated early, the survival rate is high. This is one of the reasons that population-based screening programs for the early detection of CRC using the faecal immunochemical test (FIT) started worldwide. These programs compete with regular colonoscopy programs and increase the waiting time for symptomatic patients. However, the literature has shown that the correlation between intestinal complaints and the gain of colonoscopy is poor. The aim of this study is to assess the diagnostic utility of symptoms for the yield (CRC) of colonoscopy and to compare this with the diagnostic utility of FIT when offered to symptomatic patients. Methods: We performed a systematic review search for CRC as an outcome of colonoscopy in referred symptomatic patients and separately for CRC as an outcome in symptomatic patients with a positive FIT. We searched systematically for clinical trials or observational studies in databases, followed by hand-searching of reference lists. We used random Meta-Disc to evaluate the diagnostic performance, using the exploration of heterogeneity with a variety of test statistics and by computing the pooled estimates. Results: We included 35 studies, with almost 5 million symptomatic patients. In addition, we included nine prospective studies with a positive FIT in symptomatic patients, with more than 5000 patients. Significant heterogeneity was found for every symptom and the outcome of colonoscopy in the effect size of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio. In a random effect model, the pooled sensitivity of colonoscopy in symptomatic patients was very low (25%). However, the pooled sensitivity in symptomatic patients with a positive FIT was 83% and the pooled specificity 77%. A total of 75 symptomatic patients (1.4%) had a false-negative FIT. Conclusion: Adding FIT in symptomatic patients seems useful for predicting CRC as an outcome of colonoscopy. FIT seems a potential tool for an improved triage of colonoscopy in symptomatic patients.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference59 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann. Oncol.,2007

2. Bevolkingsonderzoek naar darmkanker;Knottnerus;Bijblijven,2009

3. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging;Maggard;J. Natl. Cancer Inst.,2004

4. Van Veldhuizen-Eshuis, H., Carpay, M.E.M., van Delden, J.A., Grievink, L., Hoebee, B., Lock, A.J.J., and Reij, R. (2011). Uitvoeringstoets Bevolkingsonderzoek Darmkanker: Opsporing van Darmkanker in Praktijk Gebracht, National Institute for Public Health and the Environment.

5. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: A systematic review;Adelstein;BMC Gastroenterol.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3